Synowledge To Host "Drug Safety Dinner And Discussion: Risk Management Planning"

Online, August 17, 2010 (Newswire.com) - Experts sharing real-world drug safety issues and a having a critical look at Risk Management Planning
London, 19 August, 2010 - Synowledge, a global provider of drug safety and Pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies, announced today that Dr. Seema Jaitly, Director, EU PV and Risk Management, QPPV will be hosting a night of dinner and discussion on behalf of Synowledge. The "Drug Safety Dinner and Discussion: 'PV Risk Management Planning'" is part of the "Synowledge EU Drug Safety Dinner and Discussion Seminar Series" which will be held in major cities throughout the European Union.
Event Details: Drug Safety Dinner and Discussion
 When: The event will take place on Thursday, Aug. 19, 2010
 Where: At the Prism London Restaurant in downtown London
 What: To discuss current challenges, trends and opportunities being faced by different Drug Safety organizations and individuals alike
 Who will be attending (invitation only): Participants come from large and small Pharmaceutical, Biotech and Life Sciences companies with titles including:
o QPPV
o Head of Pharmacovigilance
o VP (IT, Regulatory, etc.)
o Managing Director
o Head of Medical Compliance
 Host: Hosted by Dr. Seema Jaitly - Director, EU PV and Risk Management, QPPV - Synowledge
The evening will begin with a reception and be followed by the dinner and then an open-table discussion. Dinner and drinks will be served and a key-note speaker will present on "Current Trends in Risk Management Planning" which will be followed by a Q & A/roundtable discussion.
Participants of Drug Safety thought leaders will join Synowledge to discuss:
 Building common ground on drug safety issues and a having a critical look at the existing problems
 Discussing current challenges, trends and opportunities being explored by different organizations and individuals alike
 Debating key differentiators that PV providers offer to implement successful drug safety measures
 Reflections on conference deliberations
Note to Media: If any media representatives wish to reserve a spot for the event, please contact david.ingraham@synowledge.com
Note to Public: This is a private event and not open to the public.
About Dr. Seema Jaitly
As a Director, EU PV and Risk Management, Dr. Seema Jaitly provides day-to-day leadership in Synowledge's global Pharmacovigilance services including single case processing, aggregate reporting, and signal detection. She is personally involved in providing oversight for all global Pharmacovigilance projects for Synowledge. A Physician by training, Dr. Seema Jaitly comes to Synowledge with 13 years + industry experience in drug safety, clinical and med affairs. She has held various senior positions at several large Pharma companies.
About Synowledge
Synowledge is a global provider of drug safety and Pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all our clients' needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations. We have our headquarters located in Stamford CT, USA and additional offices in Bangalore, India and the United Kingdom. For more information, please visit www.synowledge.com.
###